Individuals were then identified as having NMOSD if they tested positive for anti-aquaporin-4 (AQP4) antibodies or displayed one of the key clinical symptoms (including optic neuritis (ON), myelitis, and brain disorders)3. The gene discussed is AQP4; the disease is brain disorder.